Bioqual (Bioqual) Debt-to-Revenue : 0.01 (As of May. 2018)

View and export this data going back to . Start your Free Trial

What is Bioqual Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Bioqual's Short-Term Debt & Capital Lease Obligation for the quarter that ended in May. 2018 was $0.25 Mil. Bioqual's Long-Term Debt & Capital Lease Obligation for the quarter that ended in May. 2018 was $0.00 Mil. Bioqual's annualized Revenue for the quarter that ended in May. 2018 was $35.89 Mil. Bioqual's annualized Debt-to-Revenue for the quarter that ended in May. 2018 was 0.01.

Bioqual Debt-to-Revenue Historical Data

The historical data trend for Bioqual's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual Debt-to-Revenue Chart

Bioqual Annual Data

Trend

May01

May03

May04

May05

May06

May07

May10

May11

May17

May18

Debt-to-Revenue

Get a 7-Day Free Trial

0.02

0.01

Bioqual Semi-Annual Data
	May96	May97	May98	May99	May00	May01	May03	May04	May05	May06	May07	May10	May11	May17	May18
Debt-to-Revenue	Get a 7-Day Free Trial										-	-	-	0.02	0.01

Competitive Comparison of Bioqual's Debt-to-Revenue

For the Diagnostics & Research subindustry, Bioqual's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioqual's Debt-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bioqual's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bioqual's Debt-to-Revenue falls into.

Bioqual Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Bioqual's Debt-to-Revenue for the fiscal year that ended in May. 2018 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.25	+	0)	/	35.885
	=	0.01

Bioqual's annualized Debt-to-Revenue for the quarter that ended in May. 2018 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.25	+	0)	/	35.885
	=	0.01

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (May. 2018) Revenue data.

Bioqual Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bioqual's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioqual (Bioqual) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » Debt-to-Revenue

Comparable Companies

STIM VNRX PSNL PRE MDXH ENZ TTOO BNR NOTV ACRS TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN

Traded in Other Exchanges

N/A

Address

9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850

Website

https://www.bioqual.com

Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.

Executives

Williams Frank E Jr

other: Communication, See Remarks

2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines